Management of Multiple System Atrophy
Non-Pharmacological Interventions
- The American Heart Association recommends acute water ingestion (240-480 mL) for temporary relief of orthostatic hypotension, with peak effect occurring 30 minutes after ingestion 1
- Physical counter-pressure maneuvers, such as leg crossing, lower body muscle tensing, and maximal force handgrip, can help alleviate orthostatic hypotension 1
- Compression garments (at least thigh-high, preferably including abdomen) can help improve blood pressure in patients with orthostatic hypotension 1
- Increased salt and fluid intake (6-9g salt per day) can help increase blood volume, unless contraindicated by hypertension, renal disease, or heart failure 1
Pharmacological Interventions
- Midodrine is a first-line pharmacological therapy for orthostatic hypotension, with a dose-dependent effect that increases standing blood pressure 1
- Droxidopa is particularly effective for neurogenic orthostatic hypotension in MSA patients 1
- Fludrocortisone can increase plasma volume, but should be used with caution if supine hypertension is present 1
- Pyridostigmine and Octreotide may be used for patients refractory to other treatments for orthostatic hypotension 1
Diagnostic Evaluation
- The American College of Radiology recommends MRI Brain as the optimal imaging modality for MSA diagnosis, with 3T MRI preferable over 1.5T for better resolution 2, 3
MRI findings that support MSA diagnosis include:
Finding MSA Type Putaminal atrophy, hypointensity on T2-weighted images, "hot cross bun" sign MSA-P Cerebellar and pontine atrophy, middle cerebellar peduncle hyperintensity MSA-C - Ioflupane SPECT/CT (DaTscan) demonstrates decreased radiotracer uptake in the striatum, but cannot differentiate MSA from other parkinsonian syndromes 2
- Cardiovascular autonomic testing, urodynamic studies, and sudomotor function tests can help document orthostatic hypotension and evaluate bladder dysfunction in MSA patients 2
- Advanced MRI techniques, such as diffusion tensor imaging and voxel-based morphometry, may aid in MSA diagnosis, as well as fluid biomarkers, skin biopsy, and retinal imaging biomarkers 3
Monitoring and Disease Management
- Regular monitoring of blood pressure (lying and standing) is essential for managing orthostatic hypotension 1
- Supine hypertension is a common side effect of medications used to treat orthostatic hypotension and requires careful monitoring 1
- The disease typically progresses faster than Parkinson's disease, with median survival of approximately 9.5 years from symptom onset 1
- Main differential diagnoses to consider in MSA include Parkinson's disease, Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Pure autonomic failure, Spinocerebellar ataxias, and Vascular parkinsonism 2